LIXTE Launches New Study to Determine if Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100
Provided By GlobeNewswire
Last update: Mar 31, 2025
Pre-Clinical Study in Collaboration with Netherlands Cancer Institute
is in addition to LIXTE’s Ongoing Clinical Trials for Ovarian and Colorectal Cancers
NASDAQ:LIXTW (7/23/2025, 4:30:02 PM)
0.1532
+0.02 (+11.42%)
4.15
-0.1 (-2.35%)
Find more stocks in the Stock Screener
